Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptorsValeria Camarda, David G. Lambert, D. Regoli et al.|European Journal of Pharmacology|2004Cited by 59
The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systemsDavid J. Behm, Stephen A. Douglas, Gerald P. Stankus et al.|British Journal of Pharmacology|2006Cited by 36
<i>In vitro</i> and <i>in vivo</i> pharmacological characterization of the novel UT receptor ligand [Pen<sup>5</sup>,<scp>D</scp>Trp<sup>7</sup>,Dab<sup>8</sup>]urotensin II(4–11) (UFP‐803)Valeria Camarda, Girolamo Calò, Martina Spagnol et al.|British Journal of Pharmacology|2005Cited by 32